Top Tweets for #BiteTechnology

WISK.ai @WISK_ai

over 2 years ago

Brandon Barton shares how Bite evolved from an iPad menu to a kiosk-ordering system, crucial for brands like McDonald's and Shake Shack. Learn more in the full episode: https://t.co/ZkzHu15jIe #BiteTechnology #KioskOrdering #RestaurantInnovation #BusinessInnovation

0

2

0

0

122

about 5 years ago

How does #BiTETechnology function? Who better to explain than @Amgen’s Vice President and Innovator of BiTE® Technology himself, Peter Kufer. Watch the latest #InnovationSquared full episode & learn more about our latest advancements at #ESMO21. https://t.co/ypgJXhkdL4

0

4

0

0

0

about 5 years ago

During #ESMO21, we��re highlighting our work investigating #BiTEtechnology targeting the Delta-like ligand 3 (DLL3) protein in #SCLC (small-cell lung cancer). Stay tuned for more information on our latest research.

0

3

0

1

0

about 5 years ago

As Peter Kufer, @Amgen’s VP & Innovator of BiTE® Technology, puts it, BiTE modalities give “our immune system’s T-cells a pair of eyeglasses 👓 to recognize the cancer cells so it can attack them.” Get a full view of #BiTEtechnology in our next ep. of #InnovationSquared #ESMO21

0

4

1

0

0

about 5 years ago

BiTE® technology is designed to harness the power of the immune system to target different types of cancer. #BiTETechnology

0

6

0

0

0

over 5 years ago

.@Amgen strives to help patients with cancer like Annmarie. Watch her story here: https://t.co/55UGRaBRJT #NationalCancerSurvivorMonth #BiTEtechnology

1

3

0

0

0

over 5 years ago

Annmarie received unexpected news during her 5-year checkup. Learn how she moves forward by watching the full story here: https://t.co/55UGRaBRJT #NationalCancerSurvivorMonth #BiTEtechnology

1

3

0

0

0

over 5 years ago

Dr. Peter Kufer, VP & Innovator of #BiTEtechnology, explains how the BiTE® molecule has the potential to transform the way we look at immuno-oncology. Explore #BiTEtechnology here: https://t.co/2ZAt4Xa0Jx

0

1

0

0

0

almost 6 years ago

Join us today at #SITC2020 for our oral presentation on @Amgen’s investigation of #BiTEtechnology targeting DLL3 in #SCLC (small-cell lung cancer)

AmgenOncology's tweet photo. Join us today at #SITC2020 for our oral presentation on @Amgen’s investigation of #BiTEtechnology targeting DLL3 in #SCLC (small-cell lung cancer)

0

4

0

0

0

almost 6 years ago

Join us Nov 9-14 for #SITC2020, during which we will be highlighting our work investigating #BiTEtechnology against the Delta-like protein 3 (DLL3) in small-cell lung cancer (SCLC). Learn more about this notch pathway below and follow @sitcancer for more event updates!

2

94

9

0

0

about 6 years ago

FLT3 is expressed on ~90% of AML blasts and overexpressed in >70% of patients with AML, and #BiTEtechnology is ready to challenge #AcuteMyeloidLeukemia in this next #BringBiTEtotheFight retro-sode. Learn more about FLT3 at https://t.co/VHkjxlj1l7

1

7

1

0

0

about 6 years ago

.@Amgen’s #BiTEtechnology and CAR T cell are being investigated to take on FLT3, which plays a key role in the survival or proliferation of leukemic blast cells. Learn more by watching the full retro-sode tomorrow. #BringBiTEtotheFight

5

159

29

1

0

about 6 years ago

FLT3 is expressed on ~90% of AML blasts and overexpressed in >70% of patients with #AcuteMyeloidLeukemia (AML). Stay tuned to learn how we’re targeting FLT3 with the investigational #BiTEtechnology and CAR T cell. Discover more about BiTE® molecules here: https://t.co/2ZAt4Xa0Jx

3

22

4

1

0

about 6 years ago

We’re back with another #BiTEtechnology retro-sode! Now BiTE® molecules take on PSMA in prostate cancer. Watch the video then explore this and other oncology targets at https://t.co/nS2DiI3prf

1

5

1

0

0

about 6 years ago

#BiTEtechnology is being investigated to take on prostate cancer, challenging high PSMA in prostate tissue. Like the teaser? You’ll love how we #BringBiTEtotheFight in the full retro-sode tomorrow.

7

272

47

0

0

about 6 years ago

Prostate-specific membrane antigen (PSMA) is a potential target for prostate cancer therapy. Find this and other #BiTEtechnology targets being investigated across a broad set of cancers here: https://t.co/2ZAt4XrC87

4

31

10

0

0

about 6 years ago

B cell maturation antigen (BCMA) is central to the survival of #MultipleMyeloma cells. Watch our most recent #BringBiTEtotheFight retro-sode to learn how #BiTEtechnology works. Find out more at https://t.co/JPjuJjG8Yl

1

1

2

0

0

about 6 years ago

There’s an attractive antigen target for research exploring potential novel #MultipleMyeloma therapies, and #BiTEtechnology is ready to power up! Stay tuned for the full retro-sode tomorrow. #BringBiTEtotheFight

0

79

14

0

0

about 6 years ago

BCMA is central to the survival of #MultipleMyeloma cells and represents an antigen target of interest for research exploring potential novel therapies. Learn more about #BiTEtechnology here: https://t.co/2ZAt4Xa0Jx

0

5

1

0

0

about 6 years ago

Explore the science behind investigating #BiTEtechnology to target DLL3 in small-cell lung cancer (SCLC) in our #BringBiTEtotheFight retro-sode. Visit https://t.co/6c1cnosGHz to learn more.

1

5

0

1

0

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users